Hopkinase

Hopkinase injection consists of Streptokinase 15 Lac IU which is a thrombolytic medicine and is used in hospitals for the management of some serious conditions related to blood clot formation. Streptokinase belongs to the class of fibrinolytic or thrombolytic agents and works by assisting the body dissolve blood clots that block the normal blood flow. Hopkinase is used by qualified healthcare professionals in a good clinical setting.

Composition of Hopkinase

Each vial of Hopkinase consists of:

Streptokinase – 15 Lac IU

The medicine should be prepared and administered only according to the prescribing information and the treating physician’s instructions.

How Does Hopkinase Work?

Streptokinase enhances the conversion of plasminogen into plasmin which is an enzyme that breaks down fibrin and the protein that settles down as the structural framework of blood clots. By enhancing fibrinolysis, Streptokinase can assist in dissolving an existing clot and restore blood flow in certain medical emergencies.

Because thrombolytic treatment can consist of certain risks that includes serious bleeding so Hopkinase should only be given when clinically indicated and under a medical supervision. Healthcare professionals should attentively verify the patient’s medical history and current condition along with bleeding risk and other relatable factors before treatment.

Clinical Applications of Hopkinase

Streptokinase has been used as a thrombolytic therapy in selected patients with acute thrombotic conditions. Depending on the clinical situation and applicable treatment protocols, it may be considered in certain cases of acute myocardial infarction, pulmonary embolism, and other thromboembolic conditions.

The decision to use Streptokinase depends on several factors, including the timing of the event, diagnosis, contraindications, availability of alternative treatments, and the patient’s overall health. It should never be used for self-treatment.

Administration and Precautions

Hopkinase is an injectable prescription medicine and should be administered only by trained healthcare professionals. The dosage, reconstitution procedure, route of administration, and infusion time should follow the approved product information and the physician’s prescription.

Special care is required in patients with a history of bleeding disorders, recent surgery or trauma, uncontrolled hypertension, or other conditions that may increase the risk of bleeding. Patients receiving anticoagulants or other medicines affecting blood clotting should also be carefully assessed.

Any signs of unusual or severe bleeding require immediate medical attention. Healthcare professionals should monitor patients appropriately during and after administration.

Why Choose Diya Healthcare?

Diya Healthcare Pvt. Ltd. focuses on providing pharmaceutical products with an emphasis on quality, regulatory compliance, and reliable distribution. The company maintains a broad pharmaceutical portfolio covering multiple therapeutic segments and dosage forms. Its product range includes injectable formulations for critical-care requirements.

Hopkinase, with Streptokinase 15 Lac IU, forms part of a product category designed for specialized hospital and critical-care requirements. Healthcare institutions and pharmaceutical distribution partners can contact Diya Healthcare for product availability, commercial information, and other product-related details.